Literature DB >> 26254048

Yes-associated protein (YAP) expression is involved in epithelial-mesenchymal transition in hepatocellular carcinoma.

S Wang1,2, H Li1, G Wang1, T Zhang1, B Fu1, M Ma2, Z Quan2, G Chen3.   

Abstract

PURPOSE: To investigate biological impact of the downregulation of yes-associated protein (YAP) through RNA interference in the process of epithelial-mesenchymal transition in MHCC97H and MHCC97L.
METHODS: MHCC97H and MHCC97L cells were transiently transfected by YAP-siRNA. Furthermore, protein expressions and mRNA levels of characteristic markers of epithelial-mesenchymal transition (E-cadherin, N-cadherin) were examined by Western blotting and real-time polymerase chain reaction, and transwell invasion assay was used to detect changes of invasiveness of MHCC97H and MHCC97L cells.
RESULTS: The transfected group with YAP-siRNA in MHCC97H after 72 h by Western blotting showed obviously higher expression of E-cadherin compared with the control group (P < 0.05), and lower expression of N-cadherin (P < 0.05). In MHCC97L cells, the expression of E-cadherin was also significantly increased (P < 0.05); however, N-cadherin expression did not significantly change (P > 0.05). Moreover, compared with the control group, Transwell invasion assay showed that the number of the transfected groups was significantly decreased in MHCC97H and MHCC97L cell lines (both P < 0.05). The result of real-time polymerase chain reaction indicated that mRNA levels of E-cadherin increased (P < 0.05), but the mRNA levels of N-cadherin did not significantly change (P > 0.05) in these two cell lines, indicating some effects of post-transcriptional regulation mechanism after silencing YAP.
CONCLUSIONS: YAP expression in human hepatocellular carcinoma cell lines MHCC97H and MHCC97L is closely related with the characteristic markers of epithelial-mesenchymal transition, N-cadherin and E-cadherin expression.

Entities:  

Keywords:  Epithelial–mesenchymal transition (EMT); Hepatocellular carcinoma (HCC); YAP (yes-associated protein)

Mesh:

Substances:

Year:  2015        PMID: 26254048     DOI: 10.1007/s12094-015-1353-4

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  21 in total

Review 1.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.

Authors:  Jing Yang; Robert A Weinberg
Journal:  Dev Cell       Date:  2008-06       Impact factor: 12.270

Review 2.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

3.  The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version.

Authors:  Bin Zhao; Li Li; Qunying Lei; Kun-Liang Guan
Journal:  Genes Dev       Date:  2010-05       Impact factor: 11.361

4.  Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas.

Authors:  T Matsumura; R Makino; K Mitamura
Journal:  Clin Cancer Res       Date:  2001-03       Impact factor: 12.531

5.  The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain.

Authors:  John M Lamar; Patrick Stern; Hui Liu; Jeffrey W Schindler; Zhi-Gang Jiang; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-13       Impact factor: 11.205

Review 6.  The Hippo-YAP pathway: new connections between regulation of organ size and cancer.

Authors:  Bin Zhao; Qun-Ying Lei; Kun-Liang Guan
Journal:  Curr Opin Cell Biol       Date:  2008-11-18       Impact factor: 8.382

Review 7.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

8.  Yap1 is required for endothelial to mesenchymal transition of the atrioventricular cushion.

Authors:  Hui Zhang; Alexander von Gise; Qiaozhen Liu; Tianyuan Hu; Xueying Tian; Lingjuan He; Wenjuan Pu; Xiuzhen Huang; Liang He; Chen-Leng Cai; Fernando D Camargo; William T Pu; Bin Zhou
Journal:  J Biol Chem       Date:  2014-05-15       Impact factor: 5.157

Review 9.  The hippo signaling pathway in development and cancer.

Authors:  Duojia Pan
Journal:  Dev Cell       Date:  2010-10-19       Impact factor: 12.270

10.  Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells.

Authors:  Lijuan Wang; Shengjia Shi; Zhangyan Guo; Xiang Zhang; Suxia Han; Angang Yang; Weihong Wen; Qing Zhu
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

View more
  14 in total

1.  Downregulation of YAP inhibits proliferation, invasion and increases cisplatin sensitivity in human hepatocellular carcinoma cells.

Authors:  Xiaoguang Wang; Bin Wu; Zhengxiang Zhong
Journal:  Oncol Lett       Date:  2018-05-04       Impact factor: 2.967

2.  Expression and clinical significance of YAP in laryngeal squamous cell carcinoma patients.

Authors:  Shijie Qiu; Zhaoxia Xia; Qun Li; Dong Ye; Qi Huang; Zhisen Shen
Journal:  Oncol Lett       Date:  2016-12-27       Impact factor: 2.967

3.  WWC2 is an independent prognostic factor and prevents invasion via Hippo signalling in hepatocellular carcinoma.

Authors:  Yijun Zhang; Shumei Yan; Jiewei Chen; Caixia Gan; Dong Chen; Yan Li; Jiahuai Wen; Joachim Kremerskothen; Shilu Chen; Jiangbo Zhang; Yun Cao
Journal:  J Cell Mol Med       Date:  2017-08-16       Impact factor: 5.310

4.  Effects and related mechanisms of serotonin on malignant biological behavior of hepatocellular carcinoma via regulation of Yap.

Authors:  Sushun Liu; Runchen Miao; Mimi Zhai; Qing Pang; Yan Deng; Sinan Liu; Kai Qu; Chang Liu; Jingyao Zhang
Journal:  Oncotarget       Date:  2017-07-18

5.  Suppression of miR-16 promotes tumor growth and metastasis through reversely regulating YAP1 in human cholangiocarcinoma.

Authors:  Sheng Han; Dong Wang; Guohua Tang; Xinxiang Yang; Chenyu Jiao; Renjie Yang; Yaodong Zhang; Liqun Huo; Zicheng Shao; Zefa Lu; Jiawei Zhang; Xiangcheng Li
Journal:  Oncotarget       Date:  2017-05-12

6.  Stiehopus japonieus acidic mucopolysaccharide inhibits the proliferation of pancreatic cancer SW1990 cells through Hippo-YAP pathway.

Authors:  Xiaoyu Li; Yi Liu; Cuiping Zhang; Qinghui Niu; Hui Wang; Cong Che; Man Xie; Bin Zhou; Yonghong Xu; Qi Zhang; Jun Wu; Zibin Tian
Journal:  Oncotarget       Date:  2017-03-07

7.  WWC3 inhibits epithelial-mesenchymal transition of lung cancer by activating Hippo-YAP signaling.

Authors:  Qiang Han; Joachim Kremerskothen; Xuyong Lin; Xiupeng Zhang; Xuezhu Rong; Di Zhang; Enhua Wang
Journal:  Onco Targets Ther       Date:  2018-05-08       Impact factor: 4.147

8.  MiR-195 suppresses the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by inhibiting YAP.

Authors:  Shuo Yu; Li Jing; Xiao-Ran Yin; Min-Cong Wang; Yi-Meng Chen; Ya Guo; Ke-Jun Nan; Li-Li Han
Journal:  Oncotarget       Date:  2017-09-15

9.  Lamin Mutations Cause Increased YAP Nuclear Entry in Muscle Stem Cells.

Authors:  Daniel J Owens; Martina Fischer; Saline Jabre; Sophie Moog; Kamel Mamchaoui; Gillian Butler-Browne; Catherine Coirault
Journal:  Cells       Date:  2020-03-27       Impact factor: 6.600

10.  miR-103 promotes the metastasis and EMT of hepatocellular carcinoma by directly inhibiting LATS2.

Authors:  Li-Li Han; Xiao-Ran Yin; Shu-Qun Zhang
Journal:  Int J Oncol       Date:  2018-10-01       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.